Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remissionS Rodenhuis, R de Wit, P H de Mulder, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 12, 2018
Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the NetherlandsM Timmermans, G S Sonke, W J van Driel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based studyJ M de Rijke, L J Schouten, G P M ten Velde, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel studyA K L Reyners, L de Munck, F L G Erdkamp, et al.
ESMO Open|May 9, 2022
A qualitative study on the challenges health care professionals face when caring for adolescents and young adults with an uncertain and/or poor cancer prognosisV W G Burgers, M J van den Bent, A-S E Darlington, et al.
ESMO Open|January 28, 2024
Sexual quality of life of adolescents and young adult breast cancer survivorsN J M C Vrancken Peeters, C Vlooswijk, R M Bijlsma, et al.
Breast Cancer Research and Treatment|May 18, 2011
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapyR I Lalisang, F L G Erdkamp, C J Rodenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
Pageof 3